Type 1 diabetes treatment finds new target
A new route to the regeneration of insulin in the pancreatic stem cells indicates a major breakthrough for Types 1 and 2 Diabetes therapies.
Diabetes education: one in five search results for diabetes lack reliable information
Improved, reliable diabetes education is needed for both people living with diabetes and healthcare professionals.
Omicron subvariants are better at eluding vaccines
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease
The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.
Disease X and other high priority diseases
According to the WHO, Disease X refers to a hypothetical, unknown pathogen that could cause a future epidemic.
Data capture for researching degenerative eye disease
Translational Imaging Innovations makes data accessible to research degenerative eye disease.
Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Regenerative therapies for multiple sclerosis: Clues from studying normal brain development
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
JPND: Towards a stronger brain health partnership
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
What is vasovagal syncope and why do some people faint in the sun?
Vasovagal syncope is when a person suddenly loses consciousness and faints as a result of overheating, emotional distress, or even the sight of blood.
Lager beer can lessen risk of disease in men’s gut microbes
Both alcoholic and non-alcoholic lager beer drank in moderation can improve gut microbes in men – lessening the chances of developing chronic diseases.
Using artificial intelligence to diagnose ‘glue ear’ in children
Glue ear is a common cause of hearing impairment and disability amongst children. AI can improve accuracy of diagnosis and cut down annual NHS costs.
The challenge of treating genetic diseases: The example of creatine transporter deficiency
The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.
Cerebral creatine deficiency syndrome through genetic treatments
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, addresses cerebral creatine deficiency syndrome through genetic treatments.
Lessons from the mouse model of cutaneous leishmaniasis
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
The prevalence of Brittle Bone Disease
Dr Roger J. Young, Professor at Saba University School of Medicine, walks us through Brittle Bone Disease, otherwise known as Osteogenesis Imperfecta Type I.
Research reveals that anti-TNF drug reverses Dupuytren’s disease
A clinical trial at Oxford University has found that a drug used for rheumatoid arthritis can reverse Dupuytren’s disease, if taken early on.
Huntington’s Disease: The Importance of Brain Banking
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, discuss the importance of brain banking from individuals with Huntington’s disease.
Improving the quality of life for people with brittle bone disease: Osteogenesis Imperfecta
Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.
Searching for a novel marker of preclinical Alzheimer’s disease
Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.
